Trial Search Results
An Observational Study of Hepatitis C Virus in Pregnancy
This multi-center observational study examines risk factors for HCV transmission from mother to baby.
Stanford is currently accepting patients for this trial.
The George Washington University Biostatistics Center
Collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
1. Singleton pregnancy
2. An HCV antibody positive screen (case) measured using two FDA-approved ELISA tests,
the Abbott Architect version 3.0 system and the Ortho HCV 3.0.
3. Gestational age at screening no later than 23 weeks and 6 days, and gestational age at
enrollment no later than 27 weeks and 6 days, based on clinical information and
evaluation of the earliest ultrasound as described below.
1. Planned termination of pregnancy
2. Known major fetal anomalies or demise
3. Intention of the patient or the managing obstetricians for the delivery to be outside
a MFMU Network center, unless special provisions are made to insure infant follow-up
at two and 18 months of age.
4. Participation in this study in a previous pregnancy.
5. Unwilling or unable to commit to 18 months of follow-up for HCV positive infants
Ages Eligible for Study
N/A - N/A
Genders Eligible for Study